News Alert

340B Providers, Drug Industry Raise Concerns Over HRSA’s 340B Rebate Model Pilot Proposal 

340B provider groups and drugmakers raised concerns Thursday over HRSA's proposed 340B rebate guidance.
340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Survey: Most Hospitals Would Struggle to Stay Open, Maintain Care Levels Under 340B Rebate Model

340B Health surveyed hundreds of its member hospitals on the likely effects of drugmakers' proposed 340B rebate models.
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dark Money Group’s Survey Claims GOP Primary Voters Oppose State Contract Pharmacy Access Laws

Dark money group Building America’s Future said it surveyed more than 1,000 likely GOP primary voters on their support for “expanding” the 340B program by states passing contract pharmacy access bills.
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Budget Reconciliation’s Effects Could Shape Efforts to Reform 340B, Policy Experts Say at 340B Coalition Conference

Tom O’Donnell (left) and Michael McCaughan (right) speak at the 340B Coalition Summer Conference in National Harbor, Md.
The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Exempts New States from 340B Contract Pharmacy Restrictions, Teva Issues New Update on Restricted Drugs

GSK and Teva recently announced new changes to their 340B contract pharmacy restrictions.
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live